Journal of Epidemiology and Global Health (Oct 2023)

A Population-Based Outcome-Wide Association Study of the Comorbidities and Sequelae Following COVID-19 Infection

  • Yuyang Zhang,
  • Junhong Li,
  • Lan Feng,
  • Yaxin Luo,
  • Wendu Pang,
  • Ke Qiu,
  • Minzi Mao,
  • Yao Song,
  • Danni Cheng,
  • Yufang Rao,
  • Xinyi Wang,
  • Yao Hu,
  • Zhiye Ying,
  • Xiaobin Pu,
  • Shuyan Lin,
  • Shaohui Huang,
  • Geoffrey Liu,
  • Wei Zhang,
  • Wei Xu,
  • Yu Zhao,
  • Jianjun Ren

DOI
https://doi.org/10.1007/s44197-023-00161-w
Journal volume & issue
Vol. 13, no. 4
pp. 870 – 885

Abstract

Read online

Abstract Background Immense attention has been given to the outcome of COVID-19 infection. However, comprehensive studies based on large populational cohort with long-term follow-up are still lacking. This study aimed to investigate the risk of various short-term comorbidities (within one month) and long-term sequelae (above one month) after COVID-19 infection. Methods In this large prospective cohort study with 14 months follow-up information based on UK biobank, we included 16,776 COVID-19-positive participants and 58,281 COVID-19-negative participants matched for comparison. The risk of each comorbidity and sequela was evaluated by multivariable logistic regression analysis and presented as hazard ratio (HR) and 95% confidence interval (95% CI). Results COVID-19-positive individuals had a higher risk of 47 types of comorbidities within one month following COVID-19 infection, especially those who were older, male, overweight/obese, ever-smoked, with more pre-existing comorbidities and hospitalized. About 70.37% of COVID-19 patients with comorbidities had more than one co-occurring comorbidities. Additionally, only 6 high-risk sequelae were observed after one month of COVID-19 infection, and the incidence was relatively low (< 1%). Conclusion In addition to long-term sequelae following COVID-19 infection, plenty of comorbidities were observed, especially in patients with older age, male gender, overweight/obese, more pre-existing comorbidities and severe COVID-19, indicating that more attention should be given to these susceptible persons within this period.

Keywords